← Back to Patent Explorer
US5152758A Expired / Lapsed US ⏱️ 0.0 years remaining

Electroresponsive hydrogel and physiologically active substance release control system

Assignee: Senju Pharmaceutical Co Ltd
•
Filing: 1990-07-23
•
Granted: 1992-10-06
•
Expires: 2010-07-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An electroresponsive hydrogel produced by alkali hydrolysis of a copolymer comprising N-isopropylacrylamide, an ionic monomer and a crosslinking agent; and a physiologically active substance release control system comprising a biosensor, an amplifier and an electroresponsive hydrogel containing physiologically active substance are disclosed. The hydrogel of the present invention is capable of releasing a physiologically active substance alone in an amount corresponding to the applied voltage with excellent reproducibility by contracting and reswelling in good response to the loading and unloading of an external stimulation voltage, it can be advantageously used in a physiologically active substance release control system capable of releasing an essential physiologically active substance in a necessary amount according to changes in physiological conditions. Also, the physiologically active substance release control system of the present invention using this hydrogel is useful for the treatment of various diseases including diabetes mellitus.

Inventors

  • 👤 Isao Kaetsu
  • 👤 Yasushi Morita
  • 👤 Akira Ohtori

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 20:04
CPC Classifications
A; A61; A61M; A61M35/00; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/22; A61K38/28; A61K9/00; A61K9/0002; A61K9/0009; A61K9/20; A61K9/2004; A61K9/2022; A61K9/2027

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 90 words
A physiologically active substance release control system which comprises: a biosensor for sensing the presence of an indicator chemical substance in vivo and for generating an electrical output voltage dependent upon the concentration of said indicator chemical substance in vivo, an amplifier for receiving said electrical output voltage and for amplifying said voltage and providing an output signal corresponding thereto, and an electroresponsive hydrogel containing a physiologically active substance for receiving said output signal from said amplifier and for contracting in response thereto, thereby releasing said physiologically active substance therefrom.
Claim 2
Dependent Claim 90 words
A physiologically active substance release control system which comprises: a biosensor for sensing the presence of an indicator chemical substance in vivo and for generating an electrical output voltage dependent upon the concentration of said indicator chemical substance in vivo, an amplifier for receiving said electrical output voltage and for amplifying said voltage and providing an output signal corresponding thereto, and an electroresponsive hydrogel containing a physiologically active substance for receiving said output signal from said amplifier and for contracting in response thereto, thereby releasing said physiologically active substance therefrom.
Claim 3
Dependent Claim 29 words
A physiologically active substance release control system as claimed in claim 1 wherein the biosensor is an ion sensitive field effect transistor having an enzyme immobilized on its element.
Claim 4
Dependent Claim 30 words
A physiologically active substance release control system as claimed in claim 2 wherein the indicator chemical substance is a substance capable of reacting with said enzyme to produce hydrogen ions.
Claim 5
Dependent Claim 39 words
A physiologically active substance release control system as claimed in claim 1 wherein the biosensor is produced by coating a photocuring resin mixed with a particular enzyme on said element by dipping and immobilizing it by near ultraviolet irradiation.
Claim 6
Dependent Claim 32 words
A physiologically active substance release control system as claimed in claim 1 wherein the amplifier is capable of amplifying the voltage from the biosensor at a constant rate of about 1000 fold.
Claim 7
Dependent Claim 34 words
A physiologically active substance release control system as claimed in claim 1 wherein the electroresponsive hydrogel is prepared by the alkali hydrolysis of a copolymer comprising N-isopropylacrylamide, an ionic monomer and a crosslinking agent.
Claim 8
Dependent Claim 50 words
A physiologically active substance release control system as claimed in claim 1 wherein the electroresponsive hydrogel is produced by hydrolyzing a copolymer comprising 100 parts by weight of N-isopropylacrylamide, 5 to 50 parts by weight of an ionic monomer and 2 to 15 parts by weight of a crosslinking agent.
Claim 9
Dependent Claim 50 words
A physiologically active substance release control system as claimed in claim 1 wherein the electroresponsive hydrogel is produced by hydrolyzing a copolymer comprising 100 parts by weight of N-isopropylacrylamide, 10 to 40 parts by weight of an ionic monomer and 5 to 10 parts by weight of a crosslinking agent.
Claim 10
Dependent Claim 19 words
A physiologically active substance release control system as claimed in claim 1 wherein the physiologically active substance is insulin.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-10-06 1996-04-06 1996-10-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-10-06 2000-04-06 2000-10-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-10-06 2004-04-06 2004-10-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag